Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

The Utility of Expert Diagnosis in Surgical Neuropathology: Analysis of Consultations Reviewed at 5 National Comprehensive Cancer Network Institutions.

Bruner JM, Louis DN, McLendon R, Rosenblum MK, Archambault WT, Most S, Tihan T.

J Neuropathol Exp Neurol. 2017 Mar 1;76(3):189-194. doi: 10.1093/jnen/nlw122.

PMID:
28395084
2.

Persistence of 123I-mIBG Prognostic Capability in Relation to Medical Therapy in Heart Failure (from the ADMIRE-HF Trial).

PiƱa IL, Carson P, Lindenfeld J, Archambault WT, Jacobson AF.

Am J Cardiol. 2017 Feb 1;119(3):434-439. doi: 10.1016/j.amjcard.2016.10.024. Epub 2016 Oct 31.

PMID:
27912890
3.

Effect of fixed-dose combined isosorbide dinitrate/hydralazine in elderly patients in the African-American heart failure trial.

Taylor AL, Sabolinski ML, Tam SW, Ziesche S, Ghali JK, Archambault WT, Worcel M, Cohn JN; A-HeFT Investigators.

J Card Fail. 2012 Aug;18(8):600-6. doi: 10.1016/j.cardfail.2012.06.526.

PMID:
22858074
4.

Civamide cream 0.075% in patients with osteoarthritis of the knee: a 12-week randomized controlled clinical trial with a longterm extension.

Schnitzer TJ, Pelletier JP, Haselwood DM, Ellison WT, Ervin JE, Gordon RD, Lisse JR, Archambault WT, Sampson AR, Fezatte HB, Phillips SB, Bernstein JE.

J Rheumatol. 2012 Mar;39(3):610-20. doi: 10.3899/jrheum.110192. Epub 2011 Nov 15.

PMID:
22089461
5.

Effects of bedtime very low dose cyclobenzaprine on symptoms and sleep physiology in patients with fibromyalgia syndrome: a double-blind randomized placebo-controlled study.

Moldofsky H, Harris HW, Archambault WT, Kwong T, Lederman S.

J Rheumatol. 2011 Dec;38(12):2653-63. doi: 10.3899/jrheum.110194. Epub 2011 Sep 1.

6.

Relationship of quality of life scores with baseline characteristics and outcomes in the African-American heart failure trial.

Carson P, Tam SW, Ghali JK, Archambault WT, Taylor A, Cohn JN, Braman VM, Worcel M, Anand IS.

J Card Fail. 2009 Dec;15(10):835-42. doi: 10.1016/j.cardfail.2009.05.016.

PMID:
19944359
7.

Evidence for the continued safety and tolerability of fixed-dose isosorbide dinitrate/hydralazine in patients with chronic heart failure (the extension to African-American Heart Failure Trial).

Yancy CW, Ghali JK, Braman VM, Sabolinski ML, Worcel M, Archambault WT, Franciosa JA.

Am J Cardiol. 2007 Aug 15;100(4):684-9. Epub 2007 Jun 26.

PMID:
17697829
8.

Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure Trial.

Anand IS, Tam SW, Rector TS, Taylor AL, Sabolinski ML, Archambault WT, Adams KF, Olukotun AY, Worcel M, Cohn JN.

J Am Coll Cardiol. 2007 Jan 2;49(1):32-9. Epub 2006 Dec 14.

9.

Yellow fever 17D vaccine safety and immunogenicity in the elderly.

Monath TP, Cetron MS, McCarthy K, Nichols R, Archambault WT, Weld L, Bedford P.

Hum Vaccin. 2005 Sep-Oct;1(5):207-14. Epub 2005 Sep 2.

PMID:
17012867
10.

Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys.

Monath TP, Myers GA, Beck RA, Knauber M, Scappaticci K, Pullano T, Archambault WT, Catalan J, Miller C, Zhang ZX, Shin S, Pugachev K, Draper K, Levenbook IS, Guirakhoo F.

Biologicals. 2005 Sep;33(3):131-44.

PMID:
15975826
11.

Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial.

Monath TP, Nichols R, Archambault WT, Moore L, Marchesani R, Tian J, Shope RE, Thomas N, Schrader R, Furby D, Bedford P.

Am J Trop Med Hyg. 2002 May;66(5):533-41.

PMID:
12201587
12.

Risk factors for serious nonsteroidal-induced gastrointestinal complications: regression analysis of the MUCOSA trial.

Simon LS, Hatoum HT, Bittman RM, Archambault WT, Polisson RP.

Fam Med. 1996 Mar;28(3):204-10.

PMID:
8900554

Supplemental Content

Loading ...
Support Center